Literature DB >> 2746837

Antibiotic therapy for cat-scratch disease?

C W Bogue1, J D Wise, G F Gray, K M Edwards.   

Abstract

Cat-scratch disease is usually a benign, self-limited disease that causes regional lymphadenopathy. Occasionally, it may present with systemic symptoms and have a prolonged course. To date, antibiotic therapy has not been proved to be of value. We describe three patients with cat-scratch disease who were treated successfully with gentamicin sulfate. Two patients had extensive hepatic involvement, and one patient had regional lymphadenopathy. All three patients responded within 48 hours to intravenous gentamicin. Extensive follow-up has shown no recurrence of symptoms. These cases suggest that gentamicin may be efficacious in shortening the course of cat-scratch disease. Prospective, randomized trials should be performed to confirm these results.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2746837

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  13 in total

Review 1.  Current knowledge of Bartonella species.

Authors:  M Maurin; R Birtles; D Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-07       Impact factor: 3.267

2.  Treatment of adult systemic cat scratch disease with gentamicin sulfate.

Authors:  D E Lewis; M R Wallace
Journal:  West J Med       Date:  1991-03

3.  Granulomatous hepatitis in cat-scratch disease. Ultrasound and CT observations.

Authors:  J Port; J C Leonidas
Journal:  Pediatr Radiol       Date:  1991

4.  In vitro activities of telithromycin (HMR 3647) against Rickettsia rickettsii, Rickettsia conorii, Rickettsia africae, Rickettsia typhi, Rickettsia prowazekii, Coxiella burnetii, Bartonella henselae, Bartonella quintana, Bartonella bacilliformis, and Ehrlichia chaffeensis.

Authors:  J M Rolain; M Maurin; A Bryskier; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

Review 5.  Bartonella spp. as emerging human pathogens.

Authors:  B E Anderson; M A Neuman
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

6.  Efficacy of enrofloxacin or doxycycline for treatment of Bartonella henselae or Bartonella clarridgeiae infection in cats.

Authors:  D L Kordick; M G Papich; E B Breitschwerdt
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

7.  Cat scratch disease in the United States: an analysis of three national databases.

Authors:  L A Jackson; B A Perkins; J D Wenger
Journal:  Am J Public Health       Date:  1993-12       Impact factor: 9.308

8.  Atypical presentation of cat scratch disease: Parinaud's oculoglandular syndrome with facial nerve paresis.

Authors:  Cristhian Valor; Katherine Huber
Journal:  BMJ Case Rep       Date:  2018-07-06

9.  Antibiotic susceptibilities of Afipia felis in axenic medium and in cells.

Authors:  M Maurin; H Lepocher; D Mallet; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  1993-07       Impact factor: 5.191

10.  MICs of 28 antibiotic compounds for 14 Bartonella (formerly Rochalimaea) isolates.

Authors:  M Maurin; S Gasquet; C Ducco; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  1995-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.